| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/07/2006 | EP1345939B1 Method for producing sulfonamide-substituted imidazotriazinones |
| 06/07/2006 | CN1784410A Protein kinase inhibitors |
| 06/07/2006 | CN1784409A Fused pyrimidine derivatives with CRF activity |
| 06/07/2006 | CN1784408A 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 06/07/2006 | CN1784407A Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 06/07/2006 | CN1784406A Purification and crystalline forms of zaleplon |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1784385A Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates |
| 06/07/2006 | CN1781938A Method for preparing echinocandin derivatives |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781913A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic |
| 06/07/2006 | CN1258822C Light harvesting arrays |
| 06/07/2006 | CN1258534C Cytotoxic alkaloid derivatives including asmarine A and B isolated from a sponge |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/06/2006 | US7057041 Process for the preparation of zaleplon |
| 06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 06/06/2006 | US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
| 06/06/2006 | US7057034 Titanyl phthalocyanine crystal and production method of the same, and electrophotosensitive material |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056920 useful for treating disorders or conditions that are associated with CRF or CRF1 receptors, such as anxiety disorders, depression, and stress related disorders |
| 06/06/2006 | US7056918 Benzimidazole anti-inflammatory compounds |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056913 for example, 7-methoxy-8-[n'-(4''-acridonylcarboxyamido)alkyl]-oxy-(11aS)-1,2,3,11a-tetraydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; antitumor agents |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | US7056910 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2006 | US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction |
| 06/06/2006 | CA2336582C Novel x-ray intercepting metal complexes of chlorin derivatives |
| 06/06/2006 | CA2213526C Stabilizer mixtures |
| 06/01/2006 | WO2006058120A1 Bicyclic inhibitors or rho kinase |
| 06/01/2006 | WO2006058074A1 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 06/01/2006 | WO2006057972A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 06/01/2006 | WO2006056848A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/01/2006 | WO2005049616A8 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY |
| 06/01/2006 | US20060116517 Method for increasing the cutting hardness of a molded body |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116513 such as 11-(2-dimethylamino-ethyl)-6,11-dihydro-5-thia-11-aza-benzo[a]fluoren-8-ol and 11-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-6,11-dihydro-5-thia-11-aza-benzo [a]fluoren-8-ol; selective estrogen and androgen receptor modulators |
| 06/01/2006 | US20060116511 Reacting an alkali metal salt of phthalocyanine with a metal salt, wherein the alkali metal salt of phtalocyanine is dissolved in sulfur-containing aprotic polar solvent |
| 06/01/2006 | US20060116415 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 06/01/2006 | US20060116395 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116387 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-a]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto |
| 06/01/2006 | US20060116382 Lactam compounds and their use as pharmaceuticals |
| 06/01/2006 | US20060116379 Compounds exhibiting type X sPLA2 inhibiting effect |
| 06/01/2006 | US20060116366 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/01/2006 | US20060116363 Tricyclic derivatives as ltd4 antagonists |
| 06/01/2006 | US20060116356 Phosphonate analogs of HIV integrase inhibitor compounds |
| 06/01/2006 | US20060116345 Antitumor effect potentiator and antitumor agent |
| 06/01/2006 | CA2589468A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 06/01/2006 | CA2587926A1 Bicyclic inhibitors or rho kinase |
| 06/01/2006 | CA2587894A1 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 06/01/2006 | CA2587141A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661897A1 Pyrrolopyrimidinone derivative |
| 05/31/2006 | EP1661896A1 Pyrrolopyrimidinethione derivative |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660501A2 Piperazines as oxytocin agonists |
| 05/31/2006 | EP1660500A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 05/31/2006 | EP1660456A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660444A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660095A2 Tricyclic parp inhibitors |
| 05/31/2006 | EP1660092A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1247655B1 Optical recording medium and novel azaporphyrin compounds |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0885228B1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1780841A 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the traetment of hypertension |
| 05/31/2006 | CN1780840A Pyrazolo 1,5-a pyrimidine derivatives |
| 05/31/2006 | CN1780835A Novel fused heterocycles and uses thereof. |
| 05/31/2006 | CN1780831A 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 05/31/2006 | CN1778802A Crystal form of Peimeiqusai disodium and its preparation |
| 05/31/2006 | CN1778797A Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257904C 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides |
| 05/31/2006 | CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 05/31/2006 | CN1257712C Photodynamic porphyrin antimicrobial agents |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053210 Efficient synthesis of pyropheophorbide a and its derivatives |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2282406C Catalysts and methods for catalytic oxidation |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |